Abstract
BACKGROUND: The indications for cochlear implantation (CI) are continually evolving and, as experience accumulates, the relative contraindications for CI continue to decrease. However, there is little information regarding CI in patients who may be considered to be at risk for poor wound healing due to immunosuppression or intercurrent disease. OBJECTIVE: To assess and report the complication rates, postoperative course, postimplant rehabilitation, and long-term performance of patients considered at risk due to presumably impaired healing capability. We hypothesized that these patients had outcomes similar to other implanted patients. METHODS: This is a retrospective chart review of 277 patients who have received CI at the University of Miami Ear institute between 1990 and 1999. The clinical courses of 6 patients on immunosuppressive medications and 7 patients with diseases believed to be associated with poor healing are reported. RESULTS: Long-term follow-up (mean, 33 months) showed postoperative complication rates, performance, and rehabilitation compliance that were similar to published reports of noncompromised patients. CONCLUSION: CI of selected patients with potentially reduced healing capabilities is safe and effective.
| Original language | English |
|---|---|
| Pages (from-to) | 738-741 |
| Number of pages | 4 |
| Journal | Otolaryngology - Head and Neck Surgery |
| Volume | 123 |
| Issue number | 6 |
| State | Published - Dec 20 2000 |
Fingerprint
ASJC Scopus subject areas
- Otorhinolaryngology
Cite this
Cochlear implantation in patients with compromised healing. / Odabasi, Onur; Mobley, Steven Ross; Bolanos, Rodrigo A.; Hodges, Annelle; Balkany, Thomas.
In: Otolaryngology - Head and Neck Surgery, Vol. 123, No. 6, 20.12.2000, p. 738-741.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Cochlear implantation in patients with compromised healing
AU - Odabasi, Onur
AU - Mobley, Steven Ross
AU - Bolanos, Rodrigo A.
AU - Hodges, Annelle
AU - Balkany, Thomas
PY - 2000/12/20
Y1 - 2000/12/20
N2 - BACKGROUND: The indications for cochlear implantation (CI) are continually evolving and, as experience accumulates, the relative contraindications for CI continue to decrease. However, there is little information regarding CI in patients who may be considered to be at risk for poor wound healing due to immunosuppression or intercurrent disease. OBJECTIVE: To assess and report the complication rates, postoperative course, postimplant rehabilitation, and long-term performance of patients considered at risk due to presumably impaired healing capability. We hypothesized that these patients had outcomes similar to other implanted patients. METHODS: This is a retrospective chart review of 277 patients who have received CI at the University of Miami Ear institute between 1990 and 1999. The clinical courses of 6 patients on immunosuppressive medications and 7 patients with diseases believed to be associated with poor healing are reported. RESULTS: Long-term follow-up (mean, 33 months) showed postoperative complication rates, performance, and rehabilitation compliance that were similar to published reports of noncompromised patients. CONCLUSION: CI of selected patients with potentially reduced healing capabilities is safe and effective.
AB - BACKGROUND: The indications for cochlear implantation (CI) are continually evolving and, as experience accumulates, the relative contraindications for CI continue to decrease. However, there is little information regarding CI in patients who may be considered to be at risk for poor wound healing due to immunosuppression or intercurrent disease. OBJECTIVE: To assess and report the complication rates, postoperative course, postimplant rehabilitation, and long-term performance of patients considered at risk due to presumably impaired healing capability. We hypothesized that these patients had outcomes similar to other implanted patients. METHODS: This is a retrospective chart review of 277 patients who have received CI at the University of Miami Ear institute between 1990 and 1999. The clinical courses of 6 patients on immunosuppressive medications and 7 patients with diseases believed to be associated with poor healing are reported. RESULTS: Long-term follow-up (mean, 33 months) showed postoperative complication rates, performance, and rehabilitation compliance that were similar to published reports of noncompromised patients. CONCLUSION: CI of selected patients with potentially reduced healing capabilities is safe and effective.
UR - http://www.scopus.com/inward/record.url?scp=0033669889&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033669889&partnerID=8YFLogxK
M3 - Article
C2 - 11112968
AN - SCOPUS:0033669889
VL - 123
SP - 738
EP - 741
JO - Otolaryngology - Head and Neck Surgery (United States)
JF - Otolaryngology - Head and Neck Surgery (United States)
SN - 0194-5998
IS - 6
ER -